[Considerations on the use of a new respiratory analeptic, doxapram (3,3-diphenyl-1-ethyl-4-(alpha-morpholinoethyl)-2-pyrrolidone chlorydrate) in the differential diagnosis and treatment of post-narcotic apnea].
D000328:Adult; D000368:Aged; D000758:Anesthesia; D001049:Apnea / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D004315:Doxapram / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*
D000697:Central Nervous System Stimulants; D009025:Morpholines; D011760:Pyrrolidinones; D004315:Doxapram
Considerazioni sull'impiego di un nuovo analettico respiratorio, il doxapram (3,3-difenil-1-etil-4-(alfa-morfolinoetil)-2-pirrolidone cloridrato), nella diagnosi differenziale e nel trattamento delle apnee post-narcotiche.